
|Articles|December 25, 2016
Flurry of FDA Activity Highlights AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry
3
Meeting Patients Where They Are: How Pharmacists Are Helping People Stay on Track With Schizophrenia Treatment
4
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
5

















































































































































































































